Neuromuscular Healthspan Study: Sarcopenia Intervention

神经肌肉健康寿命研究:肌肉减少症干预

基本信息

  • 批准号:
    8457576
  • 负责人:
  • 金额:
    $ 3.59万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-02-28 至 2015-02-27
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Sarcopenia, the age-related loss of muscle mass and strength, is a major health concern that contributes to the onset of frailty. Frailty and sarcopeni are major predictors of mortality, poor prognoses and loss of independence. Most importantly, the older adult with sarcopenia and/or frailty has a diminished quality of life. Identifying interventions that prevent, attenuate, and/or reverse the loss of muscle mass and strength will have a significant impact on improving the quality of life, both for basic activities of daily livig and recreational pursuits. The long-term goal of my research is to establish interventions for sarcopenia and frailty. The working hypothesis is that sarcopenia interventions will restore functional ability and extend healthspan. In preliminary work, using a cross-sectional cohort of mice to characterize age-related declines in functional and physiological ability, we developed a Neuromuscular Healthspan Scoring System to evaluate potential treatments. The next step is to test an intervention for sarcopenia. Resistance exercise is a well-accepted treatment for sarcopenia. Hence, the hypothesis for the proposed research is that resistance training will result in improved physical function, strength, and healthspan. This hypothesis will be tested with two Specific Aims: (1) Develop a resistance training model for mice and (2) Determine the effects of a resistance exercise training protocol on functional performance, muscle contractility, muscle remodeling and cellular mechanisms contributing to hypertrophy in adult, old, and aged mice. The main mechanisms to be examined include activation of the PI3k¿Akt¿mTORC1 pathway and satellite cell proliferation. The proposed studies use current technologies and approaches including mass spectrometry, single skeletal muscle fiber physiology, whole muscle physiology, and immunohistochemistry. Both mentors for this proposal, Drs. Thompson and Ferrington, are well-established scientists in the fields of aging, muscle, biochemistry and proteomics, have a strong history of successful mentorship, collaborations, funding and are well published. An advisory team, composed of experts in the fields of statistics, aging, proteomics, myogenic precursor cell biology, translational research and exercise physiology, will provide critical scientific guidance and career advice. The training program is tailored to meet my career goals by providing opportunities to enhance my scientific skill set, interact with established scientists, attend and present at national meetings, write and publish scientific papers, and mentor an undergraduate student. Lastly, the laboratories of my mentors and collaborators, the core facilities and Centers within the Medical School, and at the University of Minnesota will provide an exceptional environment for my training. I am firmly committed to studying aging in my career and will be seeking a post-doctoral position-- ultimately leading to a tenured academic appointment and becoming principle investigator of a lab at a research university. Receiving this F31 NRSA Fellowship will be a significant step towards my future success. PUBLIC HEALTH RELEVANCE: Sarcopenia, the age-related loss of skeletal muscle mass and strength, can ultimately cause the elderly to lose their independence and contribute to the onset of frailty-costing society multi- billions of dollars ($18.5 billion in direct healthcare costs in 000) and decreasing the quality of life of our senior citizens (Jannsen, et al. 2004). It is in the best interest of society, both financially and as a healthspan improvement issue, to find successful interventions for this muscle wasting condition. The overall research focus surrounding this training program is to investigate the effects of aging on skeletal muscle and to develop strategies to mitigate the effects of sarcopenia.
描述(由适用提供):与年龄相关的肌肉质量和力量损失的肌肉减少症是有助于脆弱发作的主要健康问题。脆弱和肌肉组织是死亡率,预后差和独立丧失的主要预测指标。最重要的是,患有肌肉减少症和/或脆弱的老年人的生活质量降低。确定预防,减弱和/或扭转肌肉质量和力量损失的干预措施将对改善生活质量产生重大影响,包括日常工作和娱乐活动的基本活动。我的研究的长期目标是建立干预肌肉减少症和脆弱的干预措施。工作假设是肌肉减少症干预措施将恢复功能能力并扩展健康范围。在初步工作中,使用小鼠的横截面队列来表征与年龄相关的功能和身体能力下降,我们开发了一种神经肌肉健康范围的评分系统来评估潜在的治疗方法。下一步是测试肌肉减少症的干预措施。耐药性运动是肌肉减少症的良好治疗方法。因此,拟议的研究的假设是,耐药训练将改善身体机能,力量和健康状态。该假设将以两个具体的目的进行检验:(1)为小鼠开发电阻训练模型,(2)确定阻力运动训练方案对功能性能,肌肉收缩性, 肌肉的重塑和细胞机制,导致成年,旧小鼠肥大。要研究的主要机制包括激活PI3K¿AKT¿MTORC1途径和卫星细胞增殖。拟议的研究使用当前的技术和方法,包括质谱,单个骨骼肌纤维生理学,整个肌肉生理学和免疫组织化学。该提议的两位导师,博士。汤普森(Thompson)和费林顿(Ferrington)是衰老,肌肉,生物化学和蛋白质组学领域的知名科学家,拥有成功的心态,合作,资助,并发表的悠久历史。一个由统计学,衰老,蛋白质组学,肌原性细胞生物学,翻译研究和运动生理学领域的专家组成的咨询团队将提供关键的科学指导和职业建议。该培训计划是为了实现我的职业目标而量身定制的,这是通过提供机会来增强我的科学技能集,与知名科学家互动,参加并在国家会议上互动,撰写和发表科学论文以及心理专业的本科生。最后,我的导师和合作者,医学院内的核心设施和中心的实验室以及明尼苏达大学的实验室将为我的培训提供杰出的环境。我首先致力于研究职业衰老,并将寻求博士后职位 - 最终导致终身任职任命,并成为一所研究大学实验室的主要调查员。接受此F31 NRSA奖学金将是迈向我未来成功的重要一步。 公共卫生相关性:与年龄相关的骨骼肌肉质量和力量损失,最终可能导致老年人失去独立性,并有助于成千上万美元的脆弱社会(185亿美元的直接医疗费用)的成本(000美元以000的直接医疗费用),并降低了我们的老年人的质量,并降低了我们的老年人(Jannsensensense)。最好 社会的兴趣在财务上和作为健康范围的改善问题,以寻找肌肉浪费条件的成功干预措施。围绕该培训计划的总体研究重点是研究衰老对骨骼肌的影响,并制定减轻肌肉减少症影响的策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ted G Graber其他文献

Ted G Graber的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ted G Graber', 18)}}的其他基金

Neuromuscular Healthspan Study: Sarcopenia Intervention
神经肌肉健康寿命研究:肌肉减少症干预
  • 批准号:
    8628634
  • 财政年份:
    2013
  • 资助金额:
    $ 3.59万
  • 项目类别:

相似国自然基金

城市夜间日常生活区的演进过程、活力机制与更新治理路径研究
  • 批准号:
    52378053
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
川江流域山地旧城滨水区日常生活空间与地形关系演进及其当代传承研究:以重庆为例(1891-2004)
  • 批准号:
    52308006
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
中国城市-乡村生活方式移民的乡村意象与日常生活研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
中国城市-乡村生活方式移民的乡村意象与日常生活研究
  • 批准号:
    42201250
  • 批准年份:
    2022
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
融合媒介环境学视角的日常生活空间体验研究
  • 批准号:
    42171221
  • 批准年份:
    2021
  • 资助金额:
    47 万元
  • 项目类别:
    面上项目

相似海外基金

REVAMP-PH: REpurposing Valsartan May Protect against Pulmonary Hypertension
REVAMP-PH:重新利用缬沙坦可以预防肺动脉高压
  • 批准号:
    10642368
  • 财政年份:
    2023
  • 资助金额:
    $ 3.59万
  • 项目类别:
Cognitive Health and Modifiable Factors of Daily Sleep and Activities Among Dementia Family Caregivers
痴呆症家庭护理人员的认知健康状况以及日常睡眠和活动的可改变因素
  • 批准号:
    10643624
  • 财政年份:
    2023
  • 资助金额:
    $ 3.59万
  • 项目类别:
A First-in-class Topical Immunoregulatory Therapeutic for Psoriasis
一流的牛皮癣局部免疫调节疗法
  • 批准号:
    10820331
  • 财政年份:
    2023
  • 资助金额:
    $ 3.59万
  • 项目类别:
Engineered tissue arrays to streamline deimmunized DMD gene therapy vectors
工程组织阵列可简化去免疫 DMD 基因治疗载体
  • 批准号:
    10724882
  • 财政年份:
    2023
  • 资助金额:
    $ 3.59万
  • 项目类别:
Biobehavioral Intervention to Reduce PTSD Symptoms After an ICD Shock
生物行为干预可减少 ICD 电击后的 PTSD 症状
  • 批准号:
    10722157
  • 财政年份:
    2023
  • 资助金额:
    $ 3.59万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了